Skip to main content
SpringerLink
Log in

Seizures and Illicit Drug Use

  • Chapter
Seizures

Part of the book series: Current Clinical Neurology ((CCP))

  • 328 Accesses

Abstract

Drug dependence is of two types. Psychic dependence is a psychic drive to use a drug periodically or continuously, i.e., addiction. Physical dependence is an adaptive state in which cessation of drug use or administration of an antagonist produces physical withdrawal signs. Psychic and physical dependence can exist together or independently. Tolerance refers to the need to take an ever-increasing dose of a drug to achieve the desired effect or to prevent craving or physical withdrawal (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brust JCM. Medical Aspects of Substance Abuse. Boston, MA: Butterworth-Heinemann, 1993.

    Google Scholar 

  2. Kaiko RF, Foley K, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13: 180–185.

    Article  PubMed  CAS  Google Scholar 

  3. Hershey LA. Meperidine and central neurotoxicity. Ann Intern Med 1983; 98: 548–549.

    PubMed  CAS  Google Scholar 

  4. Volavka J, Zaks A, Roubicek J, Fink M. Electroencephalographic effects of diacetylmorphine (heroine) and naloxone in man Neuropharmacology 1970; 9: 587–593.

    Article  PubMed  CAS  Google Scholar 

  5. Landow L. An apparent seizure following inadvertent intrathecal morphine. Anesthesiology 1985; 62: 545–546.

    Article  PubMed  CAS  Google Scholar 

  6. Ng SKC, Brust JCM, Hauser WA, Susser M. Illicit drug use and the risk of new onset seizures. Am J Epidemiol 1990; 132: 47–57.

    PubMed  CAS  Google Scholar 

  7. Walker GE, Yaksh TL. Studies on the effects of intrathecally injected DADL and morphine on nociceptive thresholds and electroencephalographic activity: a thalamic delta receptor syndrome. Brain Res 1986; 383: 1–14.

    Article  PubMed  CAS  Google Scholar 

  8. Sztriha L, Lelkes Z, Benedek G, et al. Potentiating effect of morphine on seizures induced by kainic acid in rats: an electroenephalographic study. Naunyn Schmied-bergs Arch Pathol 1986; 333: 47–51.

    Article  CAS  Google Scholar 

  9. Bohme GA, Stutzmann JM, Rouges BP, et al. Effects of selective mu-and deltaopioid peptides on kindled amygdaloid seizures in rats. Neurosci Lett 1987; 74: 227–231.

    Article  PubMed  CAS  Google Scholar 

  10. Czuczwar SJ, Frey HH. Effect of morphine and morphine-like analgesics on susceptibility to seizures in mice. Neuropharmacology 1986; 25: 465–469.

    Article  PubMed  CAS  Google Scholar 

  11. Tortella FC, Robles L, Holaday JW. 050488, a highly selective kappa opioid; anti-convulsant profile in rats. J Pharmacol Exp Ther 1986; 237: 49–53.

    PubMed  CAS  Google Scholar 

  12. Frey HH. Anticonvulsant effect of morphine and morphine-like analgesics in Mongolian gerbils. Pharmacology 1986; 32: 335–339.

    Article  PubMed  CAS  Google Scholar 

  13. Puglisi-Alegra S, Cabib S, Oliyerio A. Pharmacological evidence for a protective role of the endogenous opioid system on electroshock-induced seizures in the mouse. Neurosci Lett 1985; 62: 241–247.

    Article  Google Scholar 

  14. Aleman V, deMunoz DM. Effect of different convulsant drugs on some seizure parameters in morphine-dependent mice. Exp Neurol 1983; 80: 451–456.

    Article  PubMed  CAS  Google Scholar 

  15. Tortella FC. Endogenous opioid peptides and epilepsy: quieting the seizing brain? Trends Pharmacol Sci 1988; 9: 366–372.

    Article  PubMed  CAS  Google Scholar 

  16. Fulroth R, Phillips B, Durand DJ. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am J Dis Child 1989; 143: 905–910.

    PubMed  CAS  Google Scholar 

  17. Alldredge BK, Lowenstein DH, Simon RP. Seizures associated with recreational drug abuse. Neurology 1989; 39: 1037–1039.

    Article  PubMed  CAS  Google Scholar 

  18. Johnson S, O’Meara M, Young JB. Acute cocaine poisoning. Importance of treating seizures and acidosis. Am J Med 1983; 75: 1061–1064.

    Article  Google Scholar 

  19. Lowenstein DA, Masse SM, Rowbotham MC, et al. Acute neurologic and psychiatric complications associated with cocaine. Am J Med 1987; 83: 841–846.

    Article  PubMed  CAS  Google Scholar 

  20. Myers JA, Earnest MP. Generalized seizures and cocaine abuse. Neurology 1984; 34: 675–676.

    Article  PubMed  CAS  Google Scholar 

  21. Schwartz RH, Estroff T, Hoffman NG. Seizures and syncope in adolescent cocaine abusers. Am J Med 1988; 85: 462.

    Article  PubMed  CAS  Google Scholar 

  22. Harden CL, Montjo RE, Tuchman AJ, Daras M. Seizures provoked by cocaine use. Ann Neurol 1990; 28: 263–264.

    Google Scholar 

  23. Kramer LD, Locke GE, Ogunyemi A, Nelson L. Cocaine-related seizures in adults. Am J Drug Alcohol Abuse 1990; 16: 307–317.

    Article  PubMed  CAS  Google Scholar 

  24. Pascuale-Leone A, Dhuna A, Altafullah I, Anderson DC. Cocaine-induced seizures. Neurology 1990; 40: 404–407.

    Article  Google Scholar 

  25. Dhuna A, Pascual-Leone H, Langendorf F, Anderson DC. Epileptogenic properties of cocaine in humans. Neurotoxicology 1991; 12: 621–626.

    PubMed  CAS  Google Scholar 

  26. Choy-Kwong M, Lipton RB: Seizures in hospitalized cocaine users. Neurology 1989; 39: 425–427.

    Article  PubMed  CAS  Google Scholar 

  27. Washton AM, Tatarsky A. Adverse effects of cocaine abuse. In: Harris L (ed), Problems of Drug Dependence. NIDA Research Monograph 49, Washington, D.C.: DHHS, 1983, pp 247–254.

    Google Scholar 

  28. Schwartz RH, Luxenberg MG, Hoffman NG. Crack use by American middle-class adolescent polydrug abusers. J Pediatr 1991; 118: 150–155.

    Article  PubMed  CAS  Google Scholar 

  29. Ogunyemi AO, Locke GE, Kramer LD, Nelson L. Complex partial status epilepticus provoked by “crack” cocaine. Ann Neurol 1989; 26: 785–786.

    Article  PubMed  CAS  Google Scholar 

  30. Konkol RJ, Erickson BA, Doerr JK, et al. Seizures induced by the cocaine metabolite benzoylecgonine in rats. Epilepsia 1992; 33: 420.

    Article  PubMed  CAS  Google Scholar 

  31. Post RM, Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 1976; 260: 731–732.

    Article  PubMed  CAS  Google Scholar 

  32. Reith MEA, Meisler BE, Lajtha A. Locomotor effects of cocaine, cocaine congeners and local anesthetics in mice. Pharmacol Biochem Behav 1985; 23: 831–836.

    Article  PubMed  CAS  Google Scholar 

  33. Mueller SM, Solow EB. Seizures associated with a new combination “pick-me-up” pill. Ann Neurol 1982; 11: 322.

    Article  PubMed  CAS  Google Scholar 

  34. Cornelius JR, Soloff PH, Reynolds CF. Paranoia, homicidal behavior and seizures associated with phenylpropanolamine. Am J Psychiatry 1984; 141: 120–121.

    PubMed  CAS  Google Scholar 

  35. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 1992; 340: 384–387.

    Article  PubMed  CAS  Google Scholar 

  36. Wulff MH. The barbiturate withdrawal syndrome: a clinical and electrophysiologic study. Electroencephalogr Clin Neurophysiol 1959; 14 (Suppl): 1–173.

    Google Scholar 

  37. Fraser HF, Wikler A, Essig EF, Isbell H. Degree of physical dependence induced by secobarbital or pentobarbital. JAMA 1958; 166: 126–129.

    Article  CAS  Google Scholar 

  38. DuPont RL. A practical approach to benzodiazepine discontinuation. J Psychiatr Res 1990; 24 (Suppl 2): 81–90.

    Article  PubMed  Google Scholar 

  39. Nutt D. Benzodiazepine dependence in the clinic: reason for anxiety? Trends Pharmacol Sci 1986; 7: 457–460.

    Article  CAS  Google Scholar 

  40. Committee on the Review of Medicines. Systematic review of the benzodiazepines. Br Med J 1980; 1: 910–912.

    Google Scholar 

  41. Busto U, Sellers EM, Naranjo CA, et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 1986; 315: 854–859.

    Article  PubMed  CAS  Google Scholar 

  42. Schofield PR. The GABA-A receptor: molecular biology reveals a complex. Trends Pharmacol Sci 1989; 10: 476–478.

    Article  PubMed  CAS  Google Scholar 

  43. MacDonald RL, McLain MJ: Anticonvulsant drugs: mechanisms of action. Adv Neurol 1986; 44: 713.

    PubMed  CAS  Google Scholar 

  44. Myers RR, Stockard JJ. Neurologic and electroencephalographic correlates in glutethimide intoxication. Clin Pharmacol Ther 1975; 17: 212–220.

    PubMed  CAS  Google Scholar 

  45. Caplan LR, Thomas C, Banks G. Central nervous system complications of addiction to “T’s and Blues.” Neurology 1982; 32: 623–628.

    Article  PubMed  CAS  Google Scholar 

  46. Pertwee RG. The central neuropharmacology of psychotropic cannabinoids. Pharmacol Ther 1988; 36: 189–261.

    Article  PubMed  CAS  Google Scholar 

  47. Seth R, Sinha S. Chemistry and pharmacology of cannabis. Prog Drug Res 1991; 36: 71–115.

    PubMed  CAS  Google Scholar 

  48. Turkanis SA, Karler R: Central excitatory properties of delta-9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats. Neuropharmacology 1982; 21: 7–13.

    Article  PubMed  CAS  Google Scholar 

  49. Wada JA, Oswa T, Corcoran ME. Effects of tetrahydrocannabinols on kindled amygdaloid seizures in Senegalese baboons, Papio papio. Epilepsia 1975; 16: 439–448.

    Article  CAS  Google Scholar 

  50. Meldrum BS, Fariello RG, Puil EA, et al. Delta-9-tetrahydrocannabinol and epilepsy in the photosensitive baboon, Papio papio. Epilepsia 1974; 15: 255–264.

    Article  CAS  Google Scholar 

  51. Consroe P, Benedito MA, Leite JR, et al. Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice. Eur J Pharmacol 1982; 83: 293–298.

    Article  PubMed  CAS  Google Scholar 

  52. Howlett AC, Bidaut-Russell M, Devane WA, et al. The cannabinoid receptor: biochemical, anatomical, and behavioral characterization. Trends Neurosci 1990; 13: 420–423.

    Article  PubMed  CAS  Google Scholar 

  53. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946–1949.

    Article  PubMed  CAS  Google Scholar 

  54. Karler R, Turkanis SA. The cannabinoids as potential antiepileptics. J Clin Pharmacol 1981; 21: 437S - 448S.

    PubMed  CAS  Google Scholar 

  55. Consroe PF, Wood GC, Buchsbaum A. Anticonvulsant nature of marijuana smoking. JAMA 1975; 234: 306–307.

    Article  PubMed  CAS  Google Scholar 

  56. Feeney DM: Marijuana use among epileptics. JAMA 1976; 235: 1105.

    Article  PubMed  CAS  Google Scholar 

  57. Perez-Reyes M, Wingfield M. Cannabidiol and electroencephalographic epileptic activity. JAMA 1974; 230: 1635.

    Article  PubMed  CAS  Google Scholar 

  58. Cunha JM, Carlini EA, Periera AE, et al. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 1980; 21: 175–185.

    Article  PubMed  CAS  Google Scholar 

  59. Fisher D, Underleider J. Grand mal seizures following ingestion of LSD. Calif Med 1976; 106: 210–212.

    Google Scholar 

  60. Meredith TJ, Ruprah M, Little A, Flanagan RJ. Diagnosis and treatment of acute poisoning with volatile substances. Hum Toxicol 1989; 8: 277–286.

    Article  PubMed  CAS  Google Scholar 

  61. Watson JM. Solvent abuse and adolescents. Practitioner 1984; 228: 487–490.

    PubMed  CAS  Google Scholar 

  62. Skuse D, Burrell S. A review of solvent abusers and their management by a child-psychiatric outpatient service. Hum Toxicol 1982; 1: 321–329.

    Article  PubMed  CAS  Google Scholar 

  63. McCarron MM, Schulze BW, Thompson GA, et al: Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 1981; 10: 290–297.

    Article  PubMed  CAS  Google Scholar 

  64. Stockard JJ, Werner SS, Albers JA, Chippa KH. Electroencephalographic findings in phencyclidine intoxication. Arch Neurol 1976; 33: 200–203.

    Article  PubMed  CAS  Google Scholar 

  65. Kessler GF, Demers LM, Brennan RW. Phencyclidine and fatal status epilepticus. N Engl J Med 1974; 291: 979.

    PubMed  Google Scholar 

  66. Mickolich JR, Paulson GW, Cross CJ, Calhoun R: Neurologic and electroencephalographic effects of jimson weed intoxication. Clin Electroencephalogr 1976; 7: 49–57.

    Google Scholar 

Download references

Authors
  1. John C. M. Brust MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Clinical Neurological Sciences, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland

    Norman Delanty MB, FRCPI (Consultant Neurologist) (Consultant Neurologist)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Brust, J.C.M. (2002). Seizures and Illicit Drug Use. In: Delanty, N. (eds) Seizures. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-094-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-094-0_11

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-207-0

  • Online ISBN: 978-1-59259-094-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation